Cite
OP0175 Monocarboxylate Transporter (MCT)-4, Associated with the Decrease of Synovial Fluid Ph, is A Novel Therapeutic Target of Rheumatoid Arthritis
MLA
Aihiro Yamamoto, et al. “OP0175 Monocarboxylate Transporter (MCT)-4, Associated with the Decrease of Synovial Fluid Ph, Is A Novel Therapeutic Target of Rheumatoid Arthritis.” Annals of the Rheumatic Diseases, vol. 73, June 2014, p. 128.2-128. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........773399937c31b73b56d555feba8f8ec1&authtype=sso&custid=ns315887.
APA
Aihiro Yamamoto, R. Ishigaki, Toshikazu Kubo, Masataka Kohno, Hidetake Nagahara, Takahiro Seno, Akiko Kasahara, Wataru Fujii, Yutaka Kawahito, Daisaku Tokunaga, Y. Kukida, Eishi Ashihara, Tomoya Sagawa, & Ryo Oda. (2014). OP0175 Monocarboxylate Transporter (MCT)-4, Associated with the Decrease of Synovial Fluid Ph, is A Novel Therapeutic Target of Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 73, 128.2-128.
Chicago
Aihiro Yamamoto, R. Ishigaki, Toshikazu Kubo, Masataka Kohno, Hidetake Nagahara, Takahiro Seno, Akiko Kasahara, et al. 2014. “OP0175 Monocarboxylate Transporter (MCT)-4, Associated with the Decrease of Synovial Fluid Ph, Is A Novel Therapeutic Target of Rheumatoid Arthritis.” Annals of the Rheumatic Diseases 73 (June): 128.2-128. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........773399937c31b73b56d555feba8f8ec1&authtype=sso&custid=ns315887.